Literature DB >> 11345090

Induction of proliferation and augmented cytotoxicity of gammadelta T lymphocytes by bisphosphonate clodronate.

K Schilbach, A Geiselhart, R Handgretinger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11345090     DOI： 10.1182/blood.v97.9.2917

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  12 in total

1.  Cross-talk between T cells and osteoclasts in bone resorption.

Authors:  Lucia D'Amico; Ilaria Roato
Journal:  Bonekey Rep       Date:  2012-06-06

2.  Bisphosphonates target B cells to enhance humoral immune responses.

Authors:  Elena Tonti; Nereida Jiménez de Oya; Gabriele Galliverti; E Ashley Moseman; Pietro Di Lucia; Angelo Amabile; Stefano Sammicheli; Marco De Giovanni; Laura Sironi; Nicolas Chevrier; Giovanni Sitia; Luigi Gennari; Luca G Guidotti; Ulrich H von Andrian; Matteo Iannacone
Journal:  Cell Rep       Date:  2013-10-10       Impact factor: 9.423

3.  CD8+ T cells regulate bone tumor burden independent of osteoclast resorption.

Authors:  Kaihua Zhang; Seokho Kim; Viviana Cremasco; Angela C Hirbe; Lynne Collins; David Piwnica-Worms; Deborah V Novack; Katherine Weilbaecher; Roberta Faccio
Journal:  Cancer Res       Date:  2011-05-20       Impact factor: 12.701

4.  A novel mechanism of γ/δ T-lymphocyte and endothelial activation by shear stress: the role of ecto-ATP synthase β chain.

Authors:  Yi Fu; Yingjian Hou; Chenglai Fu; Mingxia Gu; Chenghong Li; Wei Kong; Xian Wang; John Y-J Shyy; Yi Zhu
Journal:  Circ Res       Date:  2010-12-30       Impact factor: 17.367

5.  Pamidronate infusion in patients with systemic sclerosis results in changes in blood mononuclear cell cytokine profiles.

Authors:  L D Carbone; K J Warrington; K D Barrow; M Pugazhenthi; M A Watsky; G Somes; J Ingels; A E Postlethwaite
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

6.  Anti-tumor cytotoxicity of gammadelta T cells expanded from peripheral blood cells of patients with myeloma and lymphoma.

Authors:  Anri Saitoh; Miwako Narita; Norihiro Watanabe; Nozomi Tochiki; Noriyuki Satoh; Jun Takizawa; Tatsuo Furukawa; Ken Toba; Yoshifusa Aizawa; Shohji Shinada; Masuhiro Takahashi
Journal:  Med Oncol       Date:  2007-09-11       Impact factor: 3.064

Review 7.  Bone metastases: When and how lung cancer interacts with bone.

Authors:  Ilaria Roato
Journal:  World J Clin Oncol       Date:  2014-05-10

8.  Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma.

Authors:  Atsushi Kurabayashi; Keiji Inoue; Hideo Fukuhara; Takashi Karashima; Satoshi Fukata; Chiaki Kawada; Taro Shuin; Mutsuo Furihata
Journal:  Cancer Sci       Date:  2015-07-14       Impact factor: 6.716

Review 9.  Interaction among cells of bone, immune system, and solid tumors leads to bone metastases.

Authors:  Ilaria Roato
Journal:  Clin Dev Immunol       Date:  2013-04-24

Review 10.  Recent developments in cell-based immune therapy for neuroblastoma.

Authors:  Michael R Verneris; John E Wagner
Journal:  J Neuroimmune Pharmacol       Date:  2007-03-02       Impact factor: 7.285
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.